GlassScriptPhysician profile
Cody Ray Christensen
NPI 1962765586
$3,635.71
in general payments reported to CMS, 2019-2025
21 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $461 · 2021: $482 · 2022: $150 · 2023: $153 · 2024: $466 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,364 · Food and Beverage: $821 · Education: $5.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,364.28 |
| Food and Beverage | $821.19 |
| Education | $5.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,134.36 | 2019-2025 | |
| Boston Scientific Corporation | $615.31 | 2019-2025 | Embold Fibered, Icefx Cryoablation System, Rezum Generator |
| Neotract INC. | $447.29 | 2019-2020 | |
| Procept Biorobotics Corporation | $402.68 | 2025 | |
| Astellas Pharma US INC | $297.13 | 2021-2022 | |
| Teleflex LLC | $210.04 | 2021-2025 | Barrigel |
| Intuitive Surgical, INC. | $190.57 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $65.64 | 2022-2025 | Prolaris |
| Axonics, INC. | $58.82 | 2023 | Bulkamid, Axonics |
| Medtronic, INC. | $30.96 | 2022-2025 | Solitaire X |
| Bayer Healthcare Pharmaceuticals INC. | $29.25 | 2025 | |
| Pfizer INC. | $24.49 | 2020 | |
| Convatec INC. | $20.64 | 2023 | |
| Abbvie INC. | $20.10 | 2025 | |
| Laborie Medical Technologies Corp. | $19.05 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14.68 | 2019 | |
| Medtronic USA, INC. | $13.28 | 2019 | |
| Sumitomo Pharma America, INC. | $12.71 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $12.08 | 2022 | |
| Srs Medical Systems, INC. | $11.62 | 2021 | |
| Travere Therapeutics, INC. | $5.01 | 2023-2024 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.